The effects of apomorphine on visual perception in patients with parkinson disease and visual hallucinations: A pilot study

Clinical Neuropharmacology

Volumn 32, Issue 5, 2009, Pages 266-268

  Geerligs, Linda ^a   Meppelink, Anne Marthe ^a   Brouwer, Wiebo H ^a   Van Laar, Teus ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Apomorphine; Attention; Parkinson disease; Visual hallucinations

Indexed keywords

APOMORPHINE; CLOZAPINE; GALANTAMINE; LEVODOPA; RIVASTIGMINE;

ARTICLE; CASE REPORT; CONTRAST SENSITIVITY; DRUG EFFECT; HUMAN; PARKINSON DISEASE; PILOT STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL HALLUCINATION;

APOMORPHINE; CONTRAST SENSITIVITY; HALLUCINATIONS; HUMANS; INFUSIONS, INTRAVENOUS; PARKINSON DISEASE; PHOTIC STIMULATION; PILOT PROJECTS; REACTION TIME; VISUAL PERCEPTION;

EID: 70349976817     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181a6a92b     Document Type: Article

References (21)

1. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:734-738. (Pubitemid 32554202)
2. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 2005;20:130-140.
3. Morgante L, Basile G, Epifanio A, et al. Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years. Arch Gerontol Geriatr 2004;9:291-296.
4. Di Rosa AE, Epifanio A, Antonini A, et al. Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease. Neurol Sci 2003;24: 174-175.
5. Ellis C, Lemmens G, Parkes JD, et al. Use of apomorphine in parkinsonian patients with neuropsychiatric complications to oral treatment. Parkinsonism Relat Disord 1997;3:103-107.
6. Buttner T, Muller T, Kuhn W. Effects of apomorphine on visual functions in Parkinson's disease. J Neural Transm 2000;107:87-94.
7. Fahn S, Elton RL, Members of the UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease, Vol.
8. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163, 293-304.
9. Dougherty BE, Flom RE, Bullimore M.A. An evaluation of the Mars Letter Contrast Sensitivity Test. Optom Vis Sci 2005;82:970-975.
10. Farnsworth D. The Farnsworth Dichotomous Test for Color Blindness. New York: The Psychological Society; 1947.
11. Warrington EK, James M. The Visual Object and Space Perception Battery (VOSP). Bury St Edmunds, England: Thames Valley Test Company; 2001.
12. Schuhfried G. Reaction testVS7. In: Test Management Program, Mödling ed. 1992.
13. Dubois B, Pillon B. Cognitive deficits in Parkinson's disease. J Neurol 1997;244:2-8.
14. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003;61:1222-1228.
15. Bos EH, Bouhuys AL, Geerts E, et al. Cognitive, physiological, and personality correlates of recurrence of depression. J Affect Disord 2005;87:221-229.
16. Quené H, van den Bergh H. On multi-level modeling of data from repeated measures designs: a tutorial. Speech Commun 2004; 43:103-121.
17. Diederich NJ, Goetz CG, Raman R, et al. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol 1998;21:289-295.
18. Frankel JP, Lees AJ, Kempster PA, et al. Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 1990;53:96-101.
19. Muller T, Benz S, Przuntek H. Apomorphine delays simple reaction time in Parkinsonian patients. Parkinsonism Relat Disord 2002; 8:357-360.
20. Alegret M, Valldeoriola F, Martí MJ, et al. Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease. Mov Disord 2004;19: 1463-1469.
21. Collerton D, Perry E, McKeith L, . Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci 2005;28:737.